Magnetar has sold KIMS Hospital to LycaHealth
KIMS is the largest independent hospital in Kent, UK, providing inpatient, day care and outpatient procedures across 35 specialties to PMI, self-pay and National Health Service (NHS)-funded patients. KIMS’ specialties span orthopedics, urology, gynecology and general surgery, to cancer care and cardiology, operating the only private interventional cardiology facility in the area.
Opened in 2014, KIMS operates a state-of-the-art, modern hospital including 95 beds and six operating theatres, plus Sevenoaks Medical Centre, a satellite diagnostics facility.
Lincoln was retained as the exclusive sell-side financial advisor, working closely with the shareholders and management team throughout the process. The Lincoln team provided both corporate finance and debt advisory services and managed all aspects of the process, including the preparatory, marketing, negotiation and due diligence phases of the transaction. KIMS was successfully sold to LycaHealth, an operator of two breast and screening diagnostic centers located in Canary Wharf and Orpington, UK.
Matthew Lee, Managing Director at Lincoln, commented, “KIMS is truly a state-of-the-art facility and market-leading care provider in Kent, UK. The investment from the exiting shareholders into the main hospital and Sevenoaks Medical Centre has positioned KIMS perfectly to assist the NHS with reducing the significant treatment backlog resulting from COVID-19 and to capitalize on growing patient preference for private pay. We look forward to seeing KIMS grow under LycaHealth’s ownership and wish the team well.”
The KIMS sale was executed during a unique time for UK healthcare, and Lincoln displayed versatility and perseverance in overcoming pandemic-related challenges. Lincoln guided us from the earliest conceptual and preparatory work through execution, skillfully navigating the negotiation to achieve a successful exit.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.